期刊文献+

生长抑制因子3在肝癌组织的表达及其临床意义 被引量:2

Clinicopathological significance of the expression of inhibitor of growth 3 in primary hepatocellular carcinoma
原文传递
导出
摘要 目的探讨生长抑制因子3(ING3)在原发性肝癌中的表达和意义。方法免疫组织化学检测105例原发性肝癌组织中ING3的表达Kendall’stan法进行相关性分析;Kaplan-Meier法绘制生存曲线,采用Log-rank检验分析;Cox比例风险回归模型分析独立预后影响因素。结果与癌旁组织比较,ING3在肝癌组织中低表达。肝癌组织中ING3低表达与肝癌肿瘤数量、分化程度、巴塞罗那临床肝癌分期标准(BCLC)、TNM分期、有无静脉浸润和有无“卫星”结节等临床病理因素之间有显著相关性(P〈0.05),而与患者性别、年龄等其他临床病理因素之间无明显相关(P〉0.05)。Cox回归分析显示ING3低表达是肝癌患者总生存率的独立影响因素[风险比(HR):2.742;95%可信区间(CI):1.270~9.959,P〈0.01],也是患者无复发生存的独立影响因素(HR:1.724;95%CI:0.856~3.940,P〈0.01)。Kaplan-Meier生存分析表明,与ING3高表达的患者比较,ING3低表达的患者总体生存(P〈0.05)和无复发生存均较差(P〈0.05)。结论ING3的表达降低参与原发性肝癌的发生发展,是原发性肝癌的独立预后影响因素。 Objective To investigated the expression of inhibitor of growth 3 ( ING3 ) and its clin- ieopathological significance in primary hepatoeellular carcinoma. Methods Immunohistochemistry was employed to detect the expression of ING3 in primary hepatoeellular carcinoma tissues of 105 patients. Cor- relation between variables was analyzed by Kendall' s tan method. Survival curves were plotted using Kap- lan - Meier method with Log - rank test. Cox proportional hazard model was used to evaluate the independ- ent prognostic factors. Results Compared with paracancerous tissues the expression level of ING3 de- creased in tumor tissues. Low expression of ING3 significantly correlated with the clinical parameters inclu- ding tumor number, differentiation, Barcelona Clinical Liver Classification (BCLC) , TNM stage, venous invasion, satellite nodules ( P 〈 0. 05 ), and showed no significant correlation with other clinical parameters including age, sex and so on. Cox regression analysis indicated that ING3 expression was independently in- fluencing factor of overall survival [ hazard ratio (HR) : 2. 742 ; 95% confidence interval (CI) : 1. 270 - 9. 959 ; P 〈 0.01 ] and recurrence - free survival ( HR : 1. 724 ; 95 % CI: 0. 856 - 3. 940 ; P 〈 0. 01 ) in liver cancer patients. Kaplan - Meier survival analysis showed that patients with low ING3 expression had poorer overall survival ( P 〈 0. 05) and poorer recurrence - free survival ( P 〈 0. 05 ) than those with high ING3 expression. Conclusion Low expression of ING3 took part in the development of primary hepatocel- lular carcinoma, and was independent prognostic factor in primary liver cancer patients.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第10期2395-2398,共4页 Chinese Journal of Experimental Surgery
关键词 生长抑制因子3 肝癌 复发 预后 Inhibitor of growth 3 Hepatocellular cancer Recurrence Prognosis
  • 相关文献

参考文献21

  • 1He GH, Helbing CC, Wagner MJ, et al. Phylogenetic analysis of the ING family of PHD finger proteins[J]. Mol Biol Evol,2005,22( 1 ) : 104-116.
  • 2Nagashima M, Shiseki M, Pedeux RM, et al. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis [ J ]. Oncogene ,2003,22 (3) :343-350.
  • 3Shimada Y, Saito A, Suzuki M, et al. Cloning of a novel gene ( ING1 L) homologous to ING1, a candidate tumor suppressor[J]. Cy- togenet Cell Genet, 1998,83 ( 3-4 ) :232-235.
  • 4Nagashima M, Shiseki M, Miura K, et al. DNA damage-inducible gene p331NG2 negatively regulates cell proliferation through acetylation of p53 [ J]. Proe Natl Acad Sci U S A,2001,98 ( 17 ) :9671-9676.
  • 5Shiseki M, Nagashima M, Pedeux RM, et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity [ J ]. Cancer Res, 2003,63 ( 10 ) : 2373-2378.
  • 6Zhang X,Xu LS,Wang ZQ,et al. ING4 induces G2/M cell cycle ar- rest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells[J]. FEBS Lett,2004,570( 1-3 ) :7-12.
  • 7Toyama T,Iwase H, Watson P, et al. Suppression of ING1 expression in sporadic breast cancer [ J ]. Oncogene, 1999,18 ( 37 ) :5187-5193.
  • 8Gou WF, Sun HZ, Zhao S, et al. Downregulated inhibitor of growth 3 ( ING3 ) expression during colorectal carcinogenesis [ J ]. Indian J Med Res,2014,139(4) :561-567.
  • 9Gunduz M, Beder LB, Gunduz E, et al. Downregulation of ING3 mRNA expression predicts poor prognosis in head and neck cancer [ J ]. Cancer Sci ,2008,99 ( 3 ) :531-538.
  • 10Wang Y, Dai DL, Martinka M, et al. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma ~ J~. Clin Cancer Res,2007,13(14) :4111-4116.

二级参考文献11

  • 1Ythier D, Larrieu D, Brambilla C, et al. The new tumor suppressor genes ING: genomic structure and status in cancer. Int J Cancer, 2008, 123 (7): 1483-1490.
  • 2Kutateladze TG. ING family of tumor suppressors. Curr Drug Targets, 2009, 10 (5): 384.
  • 3Soliman MA, Riabowol K. After a deeade of study-ING, a PHD for a versatile family of proteins. Trends Biochem Sci, 2007, 32 (11): 509-519.
  • 4Coles AH, Jones SN. The ING gene family in the regulation of cell growth and tumorigenesis. J Cell Physiol, 2009, 218 (1): 45-57.
  • 5Gong W, Suzuki K, Russell M, et al. Function of the ING family of PHD proteins in cancer, lnt J Biochem Cell Biol, 2005, 37 (5): 1054-1065.
  • 6Shiseki M, Nagashima M, Pedeux RM, et al. p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res, 2003, 63 (10): 2373-2378.
  • 7Unoki M, Kumamoto K, Takenoshita S, et al. Reviewing the current classification of inhibitor of growth family proteins. Cancer Sci, 2009, 100 (7): 1173-1179.
  • 8Ohgi T, Masaki T, Nakai S, et al. Expression of p33 (ING1) in hepatoeellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity. Scand J Gastroenterol, 2002, 37 (12): 1440-1448.
  • 9Zhu Z, Luo Z, Li Y, et al. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology, 2009, 49 (2): 504-512.
  • 10Zhang HK, Pan K, Wang H, et al. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett, 2008, 261 (2): 183-192.

共引文献7

同被引文献8

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部